Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹187.25
  • Day's High
  • ₹195.6
₹ 188.4
  • 52-w low
  • ₹163
  • 52-w high
  • ₹244.6
188.4
  • Day's open
    ₹190
  • Previous close
    ₹189.199997
  • VWAP
    ₹189.71
  • Lower price band
    ₹151.4
  • Upper price band
    ₹227

Today's Market Action

The last traded share price of Nath Bio-Genes (India) Ltd was 188.40 down by -0.42% on the NSE. Its last traded stock price on BSE was 188.40 down by -0.66%. The total volume of shares on NSE and BSE combined was 31,786 shares. Its total combined turnover was Rs 0.60 crores.

Medium and Long Term Market Action

Nath Bio-Genes (India) Ltd hit a 52-week high of 244.6 on 11-08-2023 and a 52-week low of 163 on 26-05-2023. The stock price of Nath Bio-Genes (India) Ltd is down by -5% over the last one month. It is up by 12.98% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 360

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Nath Bio-Genes (India) Ltd?

What is the Market Cap of Nath Bio-Genes (India) Ltd?

What is PE Ratio of Nath Bio-Genes (India) Ltd?

What is PB Ratio of Nath Bio-Genes (India) Ltd?

What is the CAGR of Nath Bio-Genes (India) Ltd?

How to Buy Nath Bio-Genes (India) Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 138.89% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.

Cons

  • Momentum Strength
    The stock is currently exhibiting weak momentum, & is showing weak relative strength.
  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 5.56 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.35. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Capital Allocation
    The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 70.92 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 352 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 16% of the total company's shareholding which can have a significantly negative impact on stock.

Valuation Analysis

Margin of safety
(28/05/2024)
Stock Valuation
Green line
104
50.00%
50.00% People are bullish about Nath Bio-Genes (India) Ltd
50.00%
50.00 % People are bearish about Nath Bio-Genes (India) Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Nath Bio-Genes (India) Ltd

188.40 -0.80 (-0.42%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %